벤더 중립 아카이브(VNA) 및 의료영상 저장 전송 시스템(PACS) 시장(-2031년) : 제품 유형, 모달리티, 용도, 최종사용자별

The VNA & PACS market is projected to reach USD 8.57 billion by 2031 from USD 5.60 billion in 2026, at a CAGR of 8.9%. The VNA & PACS market is seeing an increase in demand due to the evolution in the delivery of healthcare services, in which providers need imaging platforms that help coordinate care in hospitals, clinics, and diagnostic facilities. The adoption of a data-centric healthcare model has increased the demand for imaging records, which would allow clinicians to gain access to patients' medical history and help with diagnosis and treatment plans.

In addition to this, there is a demand for outpatient imaging centers, which need cloud-based PACS and VNA systems to support their imaging processes. Also, the rise in the adoption of software as a service (SaaS) business models by vendors has influenced the strategies of providers who look for flexible options and less expensive total cost of ownership models. This demand is further supported by the recent mergers and acquisitions in the industry, such as Intelerad Medical Systems Incorporated (Canada) acquired by GE HealthCare (US) in March 2026.

"By product type, the VNA segment accounted for the largest share of the VNA & PACS market in 2025."

By type of product, the VNA category will dominate the VNA & PACS market in 2025 since it provides healthcare institutions with the ability to centrally manage imaging data and ensure the sustainability of their IT infrastructure through interoperability among different systems. Through VNAs, healthcare providers can separate their data from their proprietary PACS and allow for easy information exchange without compromising system dependency issues. As stated by the Healthcare Information and Management Systems Society (2023), health facilities are shifting towards an enterprise imaging approach that stresses interoperable and vendor-neutral infrastructure to promote better patient care and improve the accessibility of their information. Similarly, according to the European Society of Radiology, long-term archiving of images and cross-enterprise data exchange have become fundamental in radiology practices today. Recent industry trends indicate that Hyland Software, Inc. (US) is developing its cloud-based VNA solution in 2025 to meet the demands of large-scale enterprises.

"By vendor type, the third-party vendor segment is expected to have the fastest growth during the forecast period."

Based on vendor type, the VNA & PACS market is segmented into independent vendors and third-party vendors. The third-party vendor market is projected to experience the highest rate of growth during the forecasted period, mainly owing to the growing demand for interoperability among different healthcare IT environments. Third-party vendors are involved in offering solutions that ensure interoperability among PACS, VNA, EHR, and various other clinical software applications so that healthcare organizations are able to integrate all of their data while maintaining their current infrastructure. As stated in a study conducted by Radsource in January 2025, PACS interoperability helps healthcare institutions become more efficient in the workflow process and improve overall patient care by exchanging data with other health systems. A recent development that shows the importance of PACS interoperability involves the enhancement of interoperable data management solutions by BridgeHead Software Ltd. (UK) and PaxeraHealth Corp. (US).

"APAC will witness the highest growth rate during the forecast period."

The VNA & PACS Market in the Asia Pacific region is witnessing robust growth due to increased spending on healthcare infrastructure, swift digitization of hospitals, and the escalating need for imaging diagnostics in a large number of patients. The governments in the region are aggressively implementing digital health strategies at the national level to facilitate better data exchange and accessibility. As per the report published by the World Health Organization (2021), nations in the Asia Pacific region are fast-tracking their digital health technology adoption to optimize the efficiency and delivery of services in health systems. Furthermore, the development of hospital chains and increased usage of electronic medical records are driving a high demand for comprehensive imaging data management systems. For example, FUJIFILM Holdings Corporation (Japan) is expanding its enterprise imaging solutions in Asia Pacific in 2025, whereas Canon Medical Systems Corporation (Japan) upgraded its imaging informatics offerings in 2025.

The breakdown of primary participants is as given below:

• By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
• By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
• By Region - North America: 35%, Europe: 30%, Asia Pacific: 25%, Latin America: 6%, Middle East & Africa: 5%

Agfa-Gevaert Group (Belgium) and Canon Medical Systems Corporation (Japan) are some of the key players in the VNA PACS market.

• The study includes an in-depth competitive analysis of these key players in the VNA PACS market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the VNA & PACS Market by Product Type (VNA [Department VNA, Multi-Department VNA, Multi-Site VNA], PACS [Department PACS, Multi-Department PACS, Multi-Site PACS]) | VNA & PACS Market, by Modality (CT, Mammography, MRI, Ultrasound, X-Rays, PET) | VNA & PACS Market, by Deployment (On-Premise Deployment, Cloud-Based Deployment, Hybrid Deployment) | VNA & PACS Market, by Vendor Type (Independent Vendor, Third-Party Vendor) | VNA & PACS Market, by Application (Cardiology, Orthopedic, Oncology, Neurology, Obstetrics and Gynecology, Other Applications) | VNA & PACS Market, by End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Other End Users) and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the VNA PACS market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; contracts, partnerships, agreements, new product & service launches, mergers & acquisitions, and recent developments associated with the VNA PACS market. Competitive analysis of upcoming startups in the VNA PACS market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the VNA & PACS market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (Heightened investments in medical imaging technologies, Growing demand for streamlined healthcare data management solutions, Integration of PACS/VNA with electronic medical records) restraints (High initial investment for implementing VNA and PACS solutions, Lack of standardized protocols and interoperability frameworks) opportunities (InFavorable government initiatives for better penetration of AI in medical imaging, Increasing medical imaging procedures and large imaging data silos, Rapid uptake of big data in healthcare) challenges (Rising security concerns related to cloud-based image processing and analytics, Data security issues in healthcare settings) influencing the growth of the VNA PACS market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the VNA & PACS Market
• Market Development: Comprehensive information about lucrative markets; the report analyses the VNA PACS market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the VNA & PACS Market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like FUJIFILM Holdings Corporation (Japan), GE HealthCare (US), Merative (US), Sectra AB (Sweden), Siemens Healthineers AG (Germany), BridgeHead Software Ltd. (UK), among others, in the VNA PACS market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING VNA & PACS MARKET
• 2.4 HIGH-GROWTH SEGMENTS
• 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ATTRACTIVE OPPORTUNITIES FOR VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
• 3.2 NORTH AMERICA VNA PACS MARKET, BY END USER AND COUNTRY
• 3.3 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Heightened investments in medical imaging technologies
    • 4.2.1.2 Growing demand for streamlined healthcare data management solutions
    • 4.2.1.3 Integration of PACS/VNA with Electronic Medical Records (EMRs)
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 High initial investment
    • 4.2.2.2 Lack of standardized protocols and interoperability frameworks
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Government initiatives to increase penetration of AI in medical imaging
    • 4.2.3.2 Increasing medical imaging procedures and large imaging data silos
    • 4.2.3.3 Rapid uptake of big data in healthcare
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Rising security concerns related to cloud-based image processing and analytics
    • 4.2.4.2 Data security issues
• 4.3 UNMET NEEDS AND WHITE SPACES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 THREAT OF NEW ENTRANTS
  • 5.1.5 THREAT OF SUBSTITUTES
• 5.2 MACROECONOMICS INDICATORS
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS AND FORECAST
  • 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
• 5.3 VALUE CHAIN ANALYSIS
• 5.4 ECOSYSTEM MAPPING
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE SELLING PRICE (ASP) TREND OF VNA AND PACS SOLUTIONS, BY PRODUCT TYPE
  • 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.6 KEY CONFERENCES AND EVENTS, 2026-2027
• 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 CASE STUDY ANALYSIS
  • 5.9.1 AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL WORLDWIDE GROWTH OF ITS MEDICAL IMAGING PLATFORM
  • 5.9.2 NHS TRUST ADOPTED INTEGRATION AND INSTANT DATA ACCESS OFFERED BY SYNAPPS VNA TO ESTABLISH UNIFIED PLATFORM FOR STORING AND MANAGING DICOM IMAGE DATA
• 5.10 IMPACT OF 2025 US TARIFF OVERVIEW
  • 5.10.1 INTRODUCTION
  • 5.10.2 KEY TARIFF RATES
  • 5.10.3 PRICE IMPACT ANALYSIS
• 5.11 IMPACT ON COUNTRY/REGION
  • 5.11.1 THE US
  • 5.11.2 EUROPE
  • 5.11.3 APAC
• 5.12 IMPACT ON END USE INDUSTRIES
• 5.13 CONCLUSION

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 DICOM (DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE)
  • 6.1.2 ENTERPRISE IMAGING SOLUTIONS
  • 6.1.3 CLOUD-BASED STORAGE AND SERVICES
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 IMAGE EXCHANGE NETWORKS
  • 6.2.2 DATA ANALYTICS AND BUSINESS INTELLIGENCE
• 6.3 ADJACENT TECHNOLOGIES
  • 6.3.1 HEALTH INFORMATION EXCHANGE (HIE)
• 6.4 PATENT ANALYSIS
  • 6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 6.5 FUTURE APPLICATIONS
  • 6.5.1 AI-ENABLED ENTERPRISE DIAGNOSTIC ORCHESTRATION
  • 6.5.2 MULTI-SPECIALTY ENTERPRISE IMAGING REPOSITORY
  • 6.5.3 IMAGING DATA LAKE FOR CLINICAL RESEARCH AND REAL-WORLD EVIDENCE
  • 6.5.4 CLOUD-BASED REGIONAL IMAGE EXCHANGE AND VIRTUAL CARE NETWORKS
  • 6.5.5 PERSONALIZED AND LONGITUDINAL IMAGING INTELLIGENCE

7 REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 REGULATIONS
    • 7.1.2.1 US
    • 7.1.2.2 Europe
    • 7.1.2.3 China
    • 7.1.2.4 Japan
    • 7.1.2.5 India
  • 7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 INTRODUCTION
• 8.2 DECISION-MAKING PROCESS
• 8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
  • 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.3.2 BUYING CRITERIA
• 8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.5.1 UNMET NEEDS
  • 8.5.2 END-USER EXPECTATIONS
• 8.6 MARKET PROFITABILITY

9 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE

• 9.1 INTRODUCTION
• 9.2 VNA
  • 9.2.1 DEPARTMENT VNA
    • 9.2.1.1 Phased imaging modernization driving VNA adoption and interoperability growth
  • 9.2.2 MULTI-DEPARTMENT VNA
    • 9.2.2.1 Cross-department imaging consolidation driving scalable enterprise data platform adoption
  • 9.2.3 MULTI-SITE VNA
    • 9.2.3.1 Cloud-based multi-site imaging consolidation enabling scalable, centralized care delivery
• 9.3 PACS
  • 9.3.1 DEPARTMENT PACS
    • 9.3.1.1 Rising imaging volumes and workforce shortages driving workflow-centric PACS adoption
  • 9.3.2 MULTI-DEPARTMENT PACS
    • 9.3.2.1 Shared imaging platforms reducing silos and enabling cross-specialty collaboration
  • 9.3.3 MULTI-SITE PACS
    • 9.3.3.1 Centralized cloud PACS enabling cross-site workload balancing and productivity gains

10 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY

• 10.1 INTRODUCTION
• 10.2 CT
  • 10.2.1 RAPID RISE IN NEED FOR CT EXAMINATIONS TO SUPPORT MARKET GROWTH
• 10.3 MAMMOGRAPHY
  • 10.3.1 RISE IN NUMBER OF MAMMOGRAPHY PROCEDURES TO DRIVE MARKET GROWTH
• 10.4 ULTRASOUND
  • 10.4.1 RISING TECHNOLOGICAL ADVANCEMENT IN ULTRASOUND DEVICES TO SUPPORT MARKET GROWTH
• 10.5 MAGNETIC RESONANCE IMAGING (MRI)
  • 10.5.1 MRI IS COST-EFFECTIVE AND EASILY AVAILABLE COMPARED TO PET
• 10.6 X-RAY
  • 10.6.1 RAPID ADOPTION OF X-RAY IMAGING COMPARED TO OTHER MODALITIES TO BOOST MARKET
• 10.7 PET
  • 10.7.1 INCREASING USE OF NUCLEAR MEDICINES TO SUPPORT POPULARITY OF PET

11 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL

• 11.1 INTRODUCTION
• 11.2 ON-PREMISE MODEL
  • 11.2.1 ON-PREMISE DEPLOYMENT MODEL PROVIDES HEALTHCARE ORGANIZATIONS WITH GREAT CONTROL AND SECURITY OVER SENSITIVE PATIENT DATA
• 11.3 CLOUD-BASED MODEL
  • 11.3.1 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE CLOUD-BASED MODEL'S POPULARITY
• 11.4 HYBRID MODEL
  • 11.4.1 UNIFIED EFFICIENCY FOR OPTIMAL PERFORMANCE TO DRIVE HYBRID VNA AND PACS SOLUTIONS

12 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE

• 12.1 INTRODUCTION
• 12.2 INDEPENDENT VENDOR
  • 12.2.1 DOMINANCE OF INDEPENDENT VENDORS TO CAPTURE SIGNIFICANT MARKET SHARE
• 12.3 THIRD-PARTY VENDOR
  • 12.3.1 NEED FOR INNOVATIVE SOLUTIONS TO FUEL SURGE IN THIRD-PARTY VENDORS' PRESENCE IN MARKET

13 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION

• 13.1 INTRODUCTION
• 13.2 CARDIOLOGY
  • 13.2.1 RISING CASES OF CARDIAC DISORDERS TO DRIVE MARKET
• 13.3 ORTHOPEDIC
  • 13.3.1 GROWTH IN CASES OF ARTHRITIS TO SUPPORT MARKET GROWTH
• 13.4 ONCOLOGY
  • 13.4.1 RISE IN NUMBER OF CANCER CASES TO DRIVE USE OF VNA AND PACS SOLUTIONS FOR ONCOLOGY
• 13.5 NEUROLOGY
  • 13.5.1 INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES TO SPUR GROWTH
• 13.6 OBSTETRICS & GYNECOLOGY
  • 13.6.1 USE OF 3D AND 4D IMAGING FOR MONITORING FETUS GROWTH AND DIAGNOSING HIGH-RISK PREGNANCIES TO DRIVE APPLICATION OF VNA AND PACS SOLUTIONS
• 13.7 OTHER APPLICATIONS

14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER

• 14.1 INTRODUCTION
• 14.2 HOSPITALS & CLINICS
  • 14.2.1 GROWING NEED TO IMPROVE PROFITABILITY OF HEALTHCARE SERVICES TO DRIVE USE OF HCIT IN HOSPITALS
• 14.3 DIAGNOSTIC CENTERS
  • 14.3.1 POPULARITY OF DIAGNOSTIC CENTERS TO PROPEL USE OF VNA AND PACS SOLUTIONS
• 14.4 AMBULATORY SURGERY CENTERS
  • 14.4.1 INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT USE OF VNA AND PACS SOLUTIONS IN AMBULATORY SURGERY CENTERS
• 14.5 OTHER END USERS

15 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION

• 15.1 INTRODUCTION
• 15.2 NORTH AMERICA
  • 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 15.2.2 US
    • 15.2.2.1 Regulatory Interoperability Mandates and Cloud-First Enterprise Imaging Strategies
  • 15.2.3 CANADA
    • 15.2.3.1 Pan-Canadian Interoperability Drive Opens Enterprise Imaging Investment Pipeline
• 15.3 EUROPE
  • 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 15.3.2 GERMANY
    • 15.3.2.1 Hospital Future Act Investment Cycle Accelerates PACS and VNA Modernization
  • 15.3.3 UK
    • 15.3.3.1 NHS Digital Diagnostic Programme and AI Mandate Catalyze GBP 700M Imaging IT Overhaul
  • 15.3.4 FRANCE
    • 15.3.4.1 Segur du Numerique Imaging Wave Drives RIS-PACS Interoperability at National Scale
  • 15.3.5 ITALY
    • 15.3.5.1 PNRR-Funded Hospital Modernization Drives PACS Replacement and Digital Imaging Upgrades
  • 15.3.6 SPAIN
    • 15.3.6.1 National Health System Digitization and Regional Imaging Network Expansion Drive Market Growth
  • 15.3.7 REST OF EUROPE
• 15.4 ASIA PACIFIC
  • 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 15.4.2 JAPAN
    • 15.4.2.1 Aging Society and Society 5.0 Strategy Drive Next-Generation PACS Replacement Cycle
  • 15.4.3 CHINA
    • 15.4.3.1 Healthy China 2030 and 14th Five-Year Plan Drive National EMR and Imaging Informatization
  • 15.4.4 INDIA
    • 15.4.4.1 Ayushman Bharat Digital Mission Creates National Imaging Data Infrastructure Demand
  • 15.4.5 REST OF ASIA PACIFIC
• 15.5 LATIN AMERICA
  • 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 15.5.2 BRAZIL
    • 15.5.2.1 SUS Hospital Modernization and Private Sector AI Imaging Adoption Drive Regional Market Leadership
  • 15.5.3 MEXICO
    • 15.5.3.1 Private Hospital Expansion and Public Sector Technology Modernization Open PACS Growth Pathway
  • 15.5.4 REST OF LATIN AMERICA
• 15.6 MIDDLE EAST & AFRICA
  • 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 15.6.2 GCC COUNTRIES
    • 15.6.2.1 Vision 2030 and National Health Digitization Investments Accelerate Smart Hospital Imaging Deployments
  • 15.6.3 REST OF MIDDLE EAST & AFRICA

16 COMPETITIVE LANDSCAPE

• 16.1 OVERVIEW
• 16.2 KEY PLAYERS' STRATEGIES/RIGHT TO WIN
  • 16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
• 16.3 REVENUE SHARE ANALYSIS
• 16.4 MARKET SHARE ANALYSIS, 2025
• 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 16.5.1 STARS
  • 16.5.2 EMERGING LEADERS
  • 16.5.3 PERVASIVE PLAYERS
  • 16.5.4 PARTICIPANTS
  • 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 16.5.5.1 Company footprint
    • 16.5.5.2 Product footprint
    • 16.5.5.3 Deployment footprint
    • 16.5.5.4 End user footprint
    • 16.5.5.5 Regional footprint
• 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 16.6.1 PROGRESSIVE COMPANIES
  • 16.6.2 RESPONSIVE COMPANIES
  • 16.6.3 DYNAMIC COMPANIES
  • 16.6.4 STARTING BLOCKS
  • 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 16.6.5.1 Detailed list of key startups/SMEs
• 16.7 COMPANY VALUATION AND FINANCIAL METRICS
• 16.8 BRAND/SOFTWARE COMPARISON
• 16.9 COMPETITIVE SCENARIO
  • 16.9.1 PRODUCT LAUNCHES & UPGRADES
  • 16.9.2 DEALS
  • 16.9.3 OTHER DEVELOPMENTS

17 COMPANY PROFILES

• 17.1 KEY COMPANIES
  • 17.1.1 AGFA-GEVAERT GROUP
    • 17.1.1.1 Business overview
    • 17.1.1.2 Solutions offered
    • 17.1.1.3 Recent developments
      • 17.1.1.3.1 Deals
    • 17.1.1.4 MnM view
      • 17.1.1.4.1 Right to win
      • 17.1.1.4.2 Strategic choices
      • 17.1.1.4.3 Weaknesses & competitive threats
  • 17.1.2 FUJIFILM HOLDINGS CORPORATION
    • 17.1.2.1 Business overview
    • 17.1.2.2 Solutions offered
    • 17.1.2.3 Recent developments
      • 17.1.2.3.1 Deals
      • 17.1.2.3.2 Other developments
    • 17.1.2.4 MnM view
      • 17.1.2.4.1 Right to win
      • 17.1.2.4.2 Strategic choices
      • 17.1.2.4.3 Weaknesses & competitive threats
  • 17.1.3 SECTRA AB
    • 17.1.3.1 Business overview
    • 17.1.3.2 Solutions offered
    • 17.1.3.3 MnM view
      • 17.1.3.3.1 Right to win
      • 17.1.3.3.2 Strategic choices
      • 17.1.3.3.3 Weaknesses & competitive threats
  • 17.1.4 GE HEALTHCARE
    • 17.1.4.1 Business overview
    • 17.1.4.2 Solutions offered
    • 17.1.4.3 Recent developments
      • 17.1.4.3.1 Product launches
      • 17.1.4.3.2 Deals
    • 17.1.4.4 MnM view
      • 17.1.4.4.1 Right to win
      • 17.1.4.4.2 Strategic choices
      • 17.1.4.4.3 Weaknesses & competitive threats
  • 17.1.5 MERATIVE
    • 17.1.5.1 Business overview
    • 17.1.5.2 Solutions offered
    • 17.1.5.3 Recent developments
      • 17.1.5.3.1 Deals
    • 17.1.5.4 MnM view
      • 17.1.5.4.1 Key strengths
      • 17.1.5.4.2 Strategic choices
      • 17.1.5.4.3 Weaknesses & competitive threats
  • 17.1.6 KONINKLIJKE PHILIPS N.V.
    • 17.1.6.1 Business overview
    • 17.1.6.2 Solutions offered
    • 17.1.6.3 Recent developments
      • 17.1.6.3.1 Product launches
      • 17.1.6.3.2 Deals
  • 17.1.7 CANON MEDICAL SYSTEMS CORPORATION
    • 17.1.7.1 Business overview
    • 17.1.7.2 Solutions offered
    • 17.1.7.3 Recent developments
      • 17.1.7.3.1 Deals
  • 17.1.8 PAXERAHEALTH
    • 17.1.8.1 Business overview
    • 17.1.8.2 Solutions offered
  • 17.1.9 NOVARAD CORPORATION
    • 17.1.9.1 Business overview
    • 17.1.9.2 Solutions offered
  • 17.1.10 HYLAND SOFTWARE, INC.
    • 17.1.10.1 Business overview
    • 17.1.10.2 Solutions offered
    • 17.1.10.3 Recent developments
      • 17.1.10.3.1 Deals
  • 17.1.11 SIEMENS HEALTHCARE LIMITED
    • 17.1.11.1 Business overview
    • 17.1.11.2 Solutions offered
    • 17.1.11.3 Recent developments
      • 17.1.11.3.1 Deals
  • 17.1.12 BRIDGEHEAD SOFTWARE LTD.
    • 17.1.12.1 Business overview
    • 17.1.12.2 Solutions offered
  • 17.1.13 CANOPY PARTNERS
    • 17.1.13.1 Business overview
    • 17.1.13.2 Solutions offered
  • 17.1.14 CRELIOHEALTH INC.
    • 17.1.14.1 Business overview
    • 17.1.14.2 Solutions offered
  • 17.1.15 ASPYRA, LLC
    • 17.1.15.1 Business overview
    • 17.1.15.2 Solutions offered
  • 17.1.16 POSTDICOM
    • 17.1.16.1 Business overview
    • 17.1.16.2 Solutions offered
  • 17.1.17 MEDICASOFT
    • 17.1.17.1 Business overview
    • 17.1.17.2 Solutions offered
  • 17.1.18 ESAOTE SPA
    • 17.1.18.1 Business overview
    • 17.1.18.2 Solutions offered
    • 17.1.18.3 Recent developments
      • 17.1.18.3.1 Product launches
  • 17.1.19 VISUS HEALTH IT GMBH
    • 17.1.19.1 Business overview
    • 17.1.19.2 Solutions offered
• 17.2 OTHER PLAYERS
  • 17.2.1 ADVAHEALTH SOLUTIONS
  • 17.2.2 SOFTTEAM SOLUTIONS PVT. LTD.
  • 17.2.3 ARO SYSTEMS
  • 17.2.4 CENTRAL DATA NETWORKS
  • 17.2.5 ONEPACS
  • 17.2.6 DEDALUS SPA.

18 RESEARCH METHODOLOGY

• 18.1 RESEARCH APPROACH
  • 18.1.1 SECONDARY RESEARCH
    • 18.1.1.1 Key data from secondary sources
  • 18.1.2 PRIMARY RESEARCH
    • 18.1.2.1 Primary sources
    • 18.1.2.2 Key data from primary sources
    • 18.1.2.3 Breakdown of primary interviews
    • 18.1.2.4 Insights from primary experts
• 18.2 RESEARCH METHODOLOGY DESIGN
• 18.3 MARKET SIZE ESTIMATION
• 18.4 DATA TRIANGULATION
• 18.5 RESEARCH ASSUMPTIONS
• 18.6 RESEARCH LIMITATIONS
  • 18.6.1 METHODOLOGY-RELATED
  • 18.6.2 SCOPE-RELATED
• 18.7 RISK ASSESSMENT

19 APPENDIX

• 19.1 DISCUSSION GUIDE
• 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 19.3 CUSTOMIZATION OPTIONS
• 19.4 RELATED REPORTS
• 19.5 AUTHOR DETAILS